Coronary disease & ACS

Changes in absolute flow, myocardial resistance and FFR after chronic total occlusion percutaneous coronary intervention

EuroInterventionPublished Prospective observational study

Authors' conclusion

Post-CTO PCI, there is a continued augmentation in absolute coronary blood flow and reduction in microvascular resistance from baseline to follow-up at 3 months. Prior CABG and a higher baseline eGFR were predictors of a larger change in absolute coronary flow, whilst an extraplaque final wire path strategy predicted a smaller change. Lastly, the patient characteristics and comorbidities had a larger influence than procedural factors on the observed change in absolute flow.

Study context

Population
Patients with a chronic total occlusion (CTO) subtending viable myocardium undergoing successful CTO percutaneous coronary intervention (PCI) (hybrid algorithm)
Participants
81 patients
Exposure
3-month follow-up vs immediately post-CTO PCI
Outcome
Recovery of absolute coronary blood flow (continuous thermodilution)
Follow-up
3-month follow-up
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

Change from immediately post-CTO PCI to follow-up · 3 months

Absolute coronary blood flow in CTO vessel increased

30%

Microvascular resistance reduced

16%

FFR increased

0.02

Observational data: associations, not effects.

Further findings

Predictors of change in absolute flow

Prior coronary artery bypass graft (CABG) and higher estimated glomerular filtration rate (eGFR) associated with larger change in absolute flow
Extraplaque strategy associated with smaller change in absolute flow

Original publication

Changes in absolute flow, myocardial resistance and FFR after chronic total occlusion percutaneous coronary intervention. EuroIntervention. Published 5 June 2023. doi:10.4244/eij-d-22-00694

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.